삼성서울병원

Ko En

Urology Jeon, Hwang Gyun M.D

Expertise
Urooncology, renal cell carcinoma, prostate cancer, bladder cancer, urothelial cancer, benign prostatic hyperplasia, Robotic operation, Laparoscopic operation
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM
Treament Schedule 06 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
AM
PM

Medical Education

Seoul National University College of Medicine

Post-Graduate Training

Fellowship   Seoul National University Hospital
Shinchon Severance hospital
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Professional Memberships

A member of the Korean Urological Association
A member of the Korean Urological Oncology Society
A member of the Korean Prostate Society

Selected Publications

  • PLOS ONE 2021 10.1371/journal.pone.0249709 Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value Chung1, JH; Jeong, JY; Lee, JY; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • BIOLOGY-BASEL 2021 10.3390/biology10040297 Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities Chung1, JH; Park, M; Cho, H; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-87573-5 Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma Kim1, TH; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-85099-4 Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma Kim1, YJ; Kang, Y; Kim, JS; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, D; Park, WY; Kang, M
    View PubMed
  • INVESTIG CLIN UROL 2021 10.4111/icu.20200406 Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance Yu1, J; Cho, E; Choi, J; Lim, JE; Lee, J; Kang, M; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed